Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pertussis: persistent pathogen, imperfect vaccines.

Sylvia H Yeh1

  • 1UCLA Center for Vaccine Research, Research and Education Institute at Harbor-UCLA Medical Center, Department of Pediatrics, Torrance, CA 90502, USA. syeh@rei.edu

Expert Review of Vaccines
|August 7, 2003
PubMed
Summary

Pertussis vaccines reduce disease but do not eliminate the pathogen. New methods are needed to improve pertussis vaccine efficacy against mild infections and interrupt transmission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment and Epidemiology of Third-Generation Cephalosporin-Resistant Urinary Tract Infections.

Pediatrics·2022
Same author

Is Acute Solid Food Aversion a Proxy for COVID-19-Related Olfactory and Gustatory Dysfunction?

Pediatrics·2021
Same author

Is Acute Solid Food Aversion a Proxy for COVID-19-Related Olfactory and Gustatory Dysfunction?

Pediatrics·2021
Same author

Profile of the Pediatric Infectious Disease Workforce in 2015.

Journal of the Pediatric Infectious Diseases Society·2018
Same author

Cost-benefit analysis of hospital based postpartum vaccination with combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap).

Vaccine·2013
Same author

Cost-benefit analysis of in-hospital influenza vaccination of postpartum women.

Obstetrics and gynecology·2012

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Routine pertussis vaccination has decreased disease incidence but has not eradicated the Bordetella pertussis pathogen.
  • Pertussis continues to pose a significant health risk, particularly to infants, adolescents, and adults.
  • Acellular pertussis vaccines offer improved safety profiles over whole-cell vaccines but may have limitations in preventing milder infections.

Purpose of the Study:

  • To highlight the ongoing challenges in pertussis control despite widespread vaccination.
  • To underscore the need for novel approaches in understanding pertussis pathogenesis and immune responses.
  • To emphasize the requirement for advanced vaccine development strategies to combat persistent pathogen transmission.

Main Methods:

  • Literature review of pertussis epidemiology and vaccine efficacy.
  • Analysis of current pertussis vaccine performance against severe and mild disease forms.
  • Discussion of emerging research methodologies for pertussis research.

Main Results:

  • Current pertussis vaccines are effective against severe disease but less so against milder infections.
  • The pertussis pathogen persists, posing a continuous threat to vulnerable populations.
  • Existing vaccine technologies may not fully address the complexities of pertussis transmission.

Conclusions:

  • Continued pertussis transmission necessitates the development of improved vaccines.
  • New methodologies are crucial for a deeper understanding of disease mechanisms and host immunity.
  • Enhanced vaccine strategies are required to effectively control and potentially eliminate pertussis.

Related Experiment Videos